BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21627382)

  • 1. Ubiquitin-specific protease 14 expression associated with intrahepatic cholangiocarcinoma cell differentiation.
    Chuensumran U; Saelee P; Punyarit P; Wongkham S; Pairojkul C; Chauin S; Petmitr S
    Asian Pac J Cancer Prev; 2011; 12(3):775-9. PubMed ID: 21627382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of DNA alterations on chromosome 17p13.2 for intrahepatic cholangiocarcinoma.
    Chuensumran U; Wongkham S; Pairojkul C; Chauin S; Petmitr S
    World J Gastroenterol; 2007 Jun; 13(21):2986-91. PubMed ID: 17589952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
    Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
    Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of overexpression and gene amplification of cyclin D1 in intrahepatic cholangiocarcinoma.
    Sugimachi K; Aishima S; Taguchi K; Tanaka S; Shimada M; Kajiyama K; Sugimachi K; Tsuneyoshi M
    J Hepatol; 2001 Jul; 35(1):74-9. PubMed ID: 11495045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulated Expression of Tropomyosin 1 in Intrahepatic Cholangiocarcinoma: A Predictor of Recurrence and Prognosis.
    Chen Y; Hong Z; Lu S; Zhang N; Rong G; Chang X; Liu Z; Bai W; Dong Z; Gao X; Zeng Z; Lu Y
    Med Sci Monit; 2018 Nov; 24():7875-7882. PubMed ID: 30390420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of HDAC8 indicates poor prognosis in patients with intrahepatic cholangiocarcinoma.
    Zhu YJ; Xu Q; Shao MY; Cao XY; Wu ZR; Chen YW; Bu H; Shi YJ
    Hepatobiliary Pancreat Dis Int; 2019 Oct; 18(5):464-470. PubMed ID: 31402267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications.
    Zhang C; Liu LX; Dong ZR; Shi GM; Cai JB; Zhang PF; Ke AW; Yu JX; Zhou J; Fan J
    Tumour Biol; 2015 Mar; 36(3):1781-9. PubMed ID: 25391422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrahepatic cholangiocarcinoma frequently shows loss of BAP1 and PBRM1 expression, and demonstrates specific clinicopathological and genetic characteristics with BAP1 loss.
    Misumi K; Hayashi A; Shibahara J; Arita J; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M
    Histopathology; 2017 Apr; 70(5):766-774. PubMed ID: 27864835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery.
    Shi RY; Yang XR; Shen QJ; Yang LX; Xu Y; Qiu SJ; Sun YF; Zhang X; Wang Z; Zhu K; Qin WX; Tang ZY; Fan J; Zhou J
    Cancer; 2013 Mar; 119(5):993-1003. PubMed ID: 23132676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological Significance of Osteopontin in Cholangiocarcinoma Cases.
    Laohaviroj M; Chamgramol Y; Pairojkul C; Mulvenna J; Sripa B
    Asian Pac J Cancer Prev; 2016; 17(1):201-5. PubMed ID: 26838210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FXR Acts as a Metastasis Suppressor in Intrahepatic Cholangiocarcinoma by Inhibiting IL-6-Induced Epithelial-Mesenchymal Transition.
    Lv B; Ma L; Tang W; Huang P; Yang B; Wang L; Chen S; Gao Q; Zhang S; Xia J
    Cell Physiol Biochem; 2018; 48(1):158-172. PubMed ID: 30001540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered Expression of Hippo Signaling Pathway Molecules in Intrahepatic Cholangiocarcinoma.
    Sugimachi K; Nishio M; Aishima S; Kuroda Y; Iguchi T; Komatsu H; Hirata H; Sakimura S; Eguchi H; Bekki Y; Takenaka K; Maehara Y; Suzuki A; Mimori K
    Oncology; 2017; 93(1):67-74. PubMed ID: 28448997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma.
    Kubo Y; Aishima S; Tanaka Y; Shindo K; Mizuuchi Y; Abe K; Shirabe K; Maehara Y; Honda H; Oda Y
    Hum Pathol; 2014 Aug; 45(8):1610-7. PubMed ID: 24824030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sox9 expression in carcinogenesis and its clinical significance in intrahepatic cholangiocarcinoma.
    Matsushima H; Kuroki T; Kitasato A; Adachi T; Tanaka T; Hirabaru M; Hirayama T; Kuroshima N; Hidaka M; Soyama A; Takatsuki M; Kinoshita N; Sano K; Nishida N; Eguchi S
    Dig Liver Dis; 2015 Dec; 47(12):1067-75. PubMed ID: 26341967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZEB1 expression is associated with prognosis of intrahepatic cholangiocarcinoma.
    Terashita K; Chuma M; Hatanaka Y; Hatanaka K; Mitsuhashi T; Yokoo H; Ohmura T; Ishizu H; Muraoka S; Nagasaka A; Tsuji T; Yamamoto Y; Kurauchi N; Shimoyama N; Toyoda H; Kumada T; Kaneoka Y; Maeda A; Ogawa K; Natsuizaka M; Kamachi H; Kakisaka T; Kamiyama T; Taketomi A; Matsuno Y; Sakamoto N
    J Clin Pathol; 2016 Jul; 69(7):593-9. PubMed ID: 26670746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological type of intrahepatic cholangiocarcinoma differentiated by genetic alteration from AP-PCR fingerprint.
    Chuensumran U; Saelee P; Wongkham S; Pairojkul C; Chauin S; Petmitr S
    Asian Pac J Cancer Prev; 2011; 12(6):1377-80. PubMed ID: 22126467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
    Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
    World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low expression of ARID1A correlates with poor prognosis in intrahepatic cholangiocarcinoma.
    Yang SZ; Wang AQ; Du J; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG
    World J Gastroenterol; 2016 Jul; 22(25):5814-21. PubMed ID: 27433094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT3 overexpression promotes metastasis in intrahepatic cholangiocarcinoma and correlates negatively with surgical outcome.
    Yang XW; Li L; Hou GJ; Yan XZ; Xu QG; Chen L; Zhang BH; Shen F
    Oncotarget; 2017 Jan; 8(5):7710-7721. PubMed ID: 28032598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.
    Su MC; Hsu C; Kao HL; Jeng YM
    Cancer Lett; 2006 Apr; 235(1):34-9. PubMed ID: 16125303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.